Tramadol Treatment for Chemotherapy-induced Mucositis Pain in Children.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 Mar 2022
01 Mar 2022
Historique:
received:
06
09
2020
accepted:
12
10
2020
pubmed:
13
11
2020
medline:
20
4
2022
entrez:
12
11
2020
Statut:
ppublish
Résumé
Mucositis, a painful and debilitating condition, is a common side effect of chemotherapy. The role of tramadol in the treatment of mucositis in pediatric patients has not yet been determined. In this retrospective study, we evaluate whether tramadol as single agent achieved a reduction of pain intensity among oncologic children admitted for mucositis. In total, 34 of 54 (63%) episodes were treated with tramadol alone and achieved adequate pain relief. Tramadol's side effects were mild and manageable.
Identifiants
pubmed: 33181582
pii: 00043426-202203000-00051
doi: 10.1097/MPH.0000000000002003
doi:
Substances chimiques
Analgesics, Opioid
0
Antineoplastic Agents
0
Tramadol
39J1LGJ30J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e487-e492Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Hurrell L, Burgoyne L, Logan R, et al. The management of pediatric oncology inpatients with oral mucositis. J Pediatr Hematol Oncol. 2019;41:e510–e516.
WHO. WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children With Medical Illnesses; 2012. Available at: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=23720867&retmode=ref&cmd=prlinks . Accessed January 1, 2012.
Wiffen PJ, Cooper TE, Anderson AK, et al. Opioids for cancer-related pain in children and adolescents. Cochrane Database Syst Rev. 2017;7:CD012564.
Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43:879–923.
Zernikow B, Smale H, Michel E, et al. Paediatric cancer pain management using the WHO analgesic ladder—results of a prospective analysis from 2265 treatment days during a quality improvement study. Eur J Pain. 2006;10:587–595.
Pendeville PE, Von Montigny S, Dort JP, et al. Double-blind randomized study of tramadol vs. paracetamol in analgesia after day-case tonsillectomy in children. Eur J Anaesthesiol. 2000;17:576–582.
WHO: WHO Handbook for Reporting Results of Cancer Treatment. World Health Organization Offset Publication, No. 48. Geneva, Switzerland: WHO; 1949.
Malviya S, Voepel-Lewis T, Tait AR, et al. Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS). Br J Anaesth. 2002;88:241–245.
Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology Group. J Clin Oncol. 2012;30:4148–4154.
US Food and Drug Administration (FDA). FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. Food and Drug Administration (FDA) Drug Safety Communications. 2017. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-restricts-use-prescription-codeine-pain-and-cough-medicines-and . Accessed April 20, 2017.
Rodieux F, Vutskits L, Posfay-Barbe KM, et al. When the safe alternative is not that safe: tramadol prescribing in children. Front Pharmacol. 2018;9:1–13.
Anderson BJ, Thomas J, Ottaway K, et al. Tramadol: keep calm and carry on. Pediatr Anaesth. 2017;27:785–788.
Chaudhry HM, Bruce AJ, Wolf RC, et al. The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: a systematic review. Biol Blood Marrow Transplant. 2016;22:605–616.
Bowen JM, Wardill HR. Advances in the understanding and management of mucositis during stem cell transplantation. Curr Opin Support Palliat Care. 2017;11:341–346.
Collins M, Wilhelm M, Conyers R, et al. Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. J Clin Oncol. 2013;31:2303–2312.
Figliolia S, Pereira MC, Lauris J, et al. Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. Oral Dis. 2008;14:761–766.
Schmiegelow K, Müller K, Mogensen SS, et al. Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. F1000Res. 2017;6:444.
Anderson PM, Lalla RV. Glutamine for amelioration of radiation and chemotherapy associated mucositis during cancer therapy. Nutrients. 2020;12:1675.
Moriyama T, Relling MV, Yang JJ. Inherited genetic variation in childhood acute lymphoblastic leukemia. Blood. 2015;125:3988–3995.
Umerez M, Garcia-Obregon S, Martin-Guerrero I, et al. Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia. Pharmacogenomics. 2018;19:361–373.